Teleflex, Inc. (TFX)

Sector:
INDUSTRIALS
Industry:
CONGLOMERATES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Benson F. Smith
Employees:
15,200
550 E SWEDESFORD RD, SUITE 400, WAYNE, PA 19087
610-225-6800

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates through the following business segments: Vascular North America, Anesthesia North America, Surgical North America, Europe, the Middle East and Africa, Asia and Original Equipment Manufacturer. The Vascular North America segment products facilitate a variety of critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. The Anesthesia North America segment provides products for clinicians working primarily in emergency rooms, surgery and critical care settings. The Surgical North America segment products are predominantly comprised of single-use products, including ligation clips and closure products; appliers and sutures used in a variety of surgical procedures; access ports used in minimally invasive laparoscopic surgical procedures, including robotic surgery, and fluid management products used for chest drainage. The Europe, Middle East and Africa segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The Asia segment, designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The Original Equipment Manufacturer segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.

Data derived from most recent annual or quarterly report
Market Cap 12.103 Billion Shares Outstanding46.902 Million Avg 30-day Volume 308.94 Thousand
P/E Ratio32.9914 Dividend Yield0.4007 EPS2.51
Price to Revenue5.7104 Debt to Equity0.5165 EBITDA868.369 Million
Price to Book Value4.2387 Operating Margin22.2974 Enterprise Value17.582 Billion
Current Ratio2.277 EPS Growth0.745 Quick Ratio1.332
1 Yr BETA 0.8451 52-week High/Low 426.56 / 244.81 Profit Margin17.3088
Operating Cash Flow Growth7.8751 Altman Z-Score3.9941 Free Cash Flow to Firm 689.355 Million
Earnings Report2022-07-28
View SEC Filings from TFX instead.

View recent insider trading info

Funds Holding TFX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TFX BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-03:
    Item 8.01: Other Events
  • 8-K: filed on 2022-05-20:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-05-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-05:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K: filed on 2022-02-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-07:
    Item 8.01: Other Events
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    3 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    3 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RANDLE STUART A

    • Director
    4,320 2022-06-07 2

    BABICH GEORGE JR

    • Director
    12,929 2022-05-03 2

    HEINMILLER JOHN C

    • Director
    3,782 2022-05-03 2

    HAGGERTY GRETCHEN R

    • Director
    4,547 2022-05-03 1

    KRAKAUER ANDREW A

    • Director
    4,905 2022-05-03 2

    KLASKO STEPHEN K. M.D.

    • Director
    10,677 2022-05-03 2

    DUNCAN CANDACE H

    • Director
    4,470 2022-05-03 1

    PATIL NEENA M

    • Director
    2,336 2022-05-03 2

    POWELL THOMAS E EXECUTIVE VICE PRESIDENT & CFO

    • Officer
    37,960 2022-02-28 1

    KELLY LIAM CHAIRMAN, PRESIDENT & CEO

    • Officer
    • Director
    68,404 2022-02-28 3

    HICKS CAMERON P CORP. VP & CHIEF HR OFFICER

    • Officer
    20,897 2022-02-28 3

    DEREN JOHN CORP. VP & CAO

    • Officer
    4,685 2022-02-28 2

    WINTERS JAMES CORP VP, MFG AND SUPPLY

    • Officer
    6,861 2022-02-28 1

    LOGUE DANIEL V. CVP, GENERAL COUNSEL & SECTY

    • Officer
    23,279 2022-02-28 1

    WHITE JAY VP & PRES, GLOBAL COMMERCIAL

    • Officer
    15,362 2022-02-28 1

    PACKER RICHARD A

    • Director
    3,784 2021-05-04 0

    LEYDEN JAMES J VP, GENERAL COUNSEL, SECRETARY

    • Officer
    No longer subject to file 2020-12-31 0

    WIJKER MARIO VICE PRESIDENT, QARA

    • Officer
    582 2020-02-25 0

    SMITH BENSON

    • Director
    47,861 2020-02-18 0

    BOYLAN KAREN VP, GLOBAL STRATEGIC PROJECTS

    • Officer
    2,258 2019-06-20 0

    KENNEDY THOMAS ANTHONY SENIOR VP, GLOBAL OPERATIONS

    • Officer
    2,863 2018-09-19 0

    FOSTER W KIM

    • Director
    3,580 2018-05-16 0

    GRAVES JEFFREY A

    • Director
    8,462 2017-05-09 0

    BARRON PATRICIA C

    • Director
    10,693 2017-02-23 0

    COOK WILLIAM ROLAND

    • Director
    20,195 2016-08-12 0

    LUBSEN SIGISMUNDUS W W

    • Director
    13,905 2015-03-16 0

    YOH HAROLD L III

    • Director
    10,277 2015-03-16 0

    ZUG JAMES W

    • Director
    10,694 2014-04-17 0

    MILLER LAURENCE G EVP, CHF ADMIN OFF, GC & SEC'Y

    • Officer
    43,928 2013-03-18 0

    MEIER RICHARD A EXEC. VICE PRES. AND CFO

    • Officer
    33,590 2012-02-28 0

    NORTHFIELD VINCENT EXEC. VP - GLOBAL OPS-MEDICAL

    • Officer
    No longer subject to file 2011-03-08 0

    WILLIAMS CHARLES EDWARD CORP. CONTROLLER AND CAO

    • Officer
    5,950 2011-03-04 0

    SUDDARTH JOHN B PRES-AEROSPACE, COMM & MED OEM

    • Officer
    17,460 2011-03-01 0

    BLACK JEFFREY P CHAIRMAN, PRESIDENT, CEO

    • Officer
    • Director
    No longer subject to file 2010-12-31 0

    WAASER R ERNEST PRESIDENT - MEDICAL

    • Officer
    20,518 2010-03-01 0

    GABORIAULT RANDALL P SR. VICE PRES. & CHF INFO OFF

    • Officer
    No longer subject to file 2009-12-31 0

    GORDON KEVIN K EXEC. VICE PRES. & CFO

    • Officer
    No longer subject to file 2009-12-31 0

    VON SELDENECK JUDITH M

    • Director
    1,908 2008-11-21 0

    MCDOWELL JULIE SR. VP CORP. COMMUNIC.

    • Officer
    430 2008-02-26 0

    SICKLER JOHN J VICE CHAIRMAN

    • Officer
    • Director
    108,264 2007-09-17 0

    HEADLEY MARTIN S EXEC. VICE PRES.& CFO

    • Officer
    6,230 2006-12-31 0

    HANDY CLARK D EXEC.VICE PRES.

    • Officer
    • HUMAN RESOURCES
    1,869 2006-11-16 0

    WHITTAKER FORREST R PRESIDENT - MEDICAL

    • Officer
    17,407 2006-02-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    RANDLE STUART A - Director

    2022-06-09 17:33:47 -0400 2022-06-07 M 3,014 d 0 direct

    RANDLE STUART A - Director

    2022-06-09 17:33:47 -0400 2022-06-07 S 3,014 $283.31 d 4,320 direct -3.0485 -8.4955 0.0 1 -8.4955 6

    RANDLE STUART A - Director

    2022-06-09 17:33:47 -0400 2022-06-07 M 3,014 $78.50 a 7,334 direct -3.0485 -8.4955 0.0 1 -8.4955 6

    KLASKO STEPHEN K. M.D. - Director

    2022-05-04 20:04:47 -0400 2022-05-03 A 399 a 1,828 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    PATIL NEENA M - Director

    2022-05-05 09:56:48 -0400 2022-05-03 A 1,937 a 1,937 direct

    PATIL NEENA M - Director

    2022-05-05 09:56:48 -0400 2022-05-03 A 399 a 399 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    RANDLE STUART A - Director

    2022-05-05 09:52:38 -0400 2022-05-03 A 969 a 969 direct

    RANDLE STUART A - Director

    2022-05-05 09:52:38 -0400 2022-05-03 A 399 a 4,320 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    HEINMILLER JOHN C - Director

    2022-05-05 09:50:53 -0400 2022-05-03 A 969 a 969 direct

    HEINMILLER JOHN C - Director

    2022-05-05 09:50:53 -0400 2022-05-03 A 399 a 1,949 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    KLASKO STEPHEN K. M.D. - Director

    2022-05-04 20:04:47 -0400 2022-05-03 A 969 a 969 direct

    BABICH GEORGE JR - Director

    2022-05-04 19:15:38 -0400 2022-05-03 A 520 a 10,960 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    KRAKAUER ANDREW A - Director

    2022-05-04 19:57:41 -0400 2022-05-03 A 969 a 969 direct

    KRAKAUER ANDREW A - Director

    2022-05-04 19:57:41 -0400 2022-05-03 A 399 a 3,936 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    HAGGERTY GRETCHEN R - Director

    2022-05-04 19:49:12 -0400 2022-05-03 A 969 a 969 direct

    HAGGERTY GRETCHEN R - Director

    2022-05-04 19:49:12 -0400 2022-05-03 A 399 a 3,578 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    DUNCAN CANDACE H - Director

    2022-05-04 19:28:25 -0400 2022-05-03 A 969 a 969 direct

    DUNCAN CANDACE H - Director

    2022-05-04 19:28:25 -0400 2022-05-03 A 399 a 3,501 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    BABICH GEORGE JR - Director

    2022-05-04 19:20:56 -0400 2022-05-03 A 969 a 969 direct

    BABICH GEORGE JR - Director

    2022-05-04 19:20:56 -0400 2022-05-03 A 520 a 10,960 direct -2.9412 -3.0744 -11.7143 5.5261 9 -11.7143 31

    BABICH GEORGE JR - Director

    2022-05-04 19:15:38 -0400 2022-05-03 A 969 a 969 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    TELEFLEX INC TFX 2022-06-24 22:15:03 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 21:45:03 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 21:15:04 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 20:45:03 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 20:15:03 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 19:45:03 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 19:15:03 UTC 1.2946 0.2754 2100000
    TELEFLEX INC TFX 2022-06-24 18:45:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 18:15:04 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 17:45:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 17:15:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 16:45:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 16:15:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 15:45:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 15:15:03 UTC 1.287 0.283 2100000
    TELEFLEX INC TFX 2022-06-24 14:45:03 UTC 1.155 0.415 2100000
    TELEFLEX INC TFX 2022-06-24 14:15:03 UTC 1.155 0.415 2100000
    TELEFLEX INC TFX 2022-06-24 13:45:03 UTC 1.155 0.415 2100000
    TELEFLEX INC TFX 2022-06-24 13:15:03 UTC 1.155 0.415 2100000
    TELEFLEX INC TFX 2022-06-24 12:45:03 UTC 1.155 0.415 2100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Advisors Series Trust- Pzena Long/Short Value Fund TFX -376.0 shares, $-136435.36 2020-05-31 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund TFX -12.0 shares, $-3514.32 2020-03-31 N-PORT
    M3Sixty Funds Trust- AXS Market Neutral Fund TFX -235.0 shares, $-96718.95 2020-12-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund TFX -38.0 shares, $-15787.48 2021-03-31 N-PORT
    Nuveen Investment Trust- Nuveen Equity Market Neutral Fund TFX -550.0 shares, $-221204.5 2021-05-31 N-PORT
    Steward Funds Inc- Steward Equity Market Neutral Fund TFX -700.0 shares, $-217133.0 2022-01-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund TFX -215.0 shares, $-76288.45 2022-03-31 N-PORT
    AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF TFX -855.0 shares, $-303379.65 2022-03-31 N-PORT

    Elevate your investments